Home  »  Business   »  Petros Pharmaceuticals Inc. (NASDAQ: PTPI) Has Bee...

Petros Pharmaceuticals Inc. (NASDAQ: PTPI) Has Been Falling -76.28% Year-To-Date. Troubles Yet To Come?

During the last session, Petros Pharmaceuticals Inc. (NASDAQ:PTPI)’s traded shares were 0.38 million. At the end of the trading day, the stock’s price was $0.79, reflecting an intraday loss of -0.27% or $0.0. The 52-week high for the PTPI share is $5.20, that puts it down -558.23 from that peak though still a striking 17.72% gain since the share price plummeted to a 52-week low of $0.65. The company’s market capitalization is $16.41M, and the average intraday trading volume over the past 10 days was 4.46 million shares, and the average trade volume was 900.20K shares over the past three months.

Petros Pharmaceuticals Inc. (NASDAQ:PTPI) trade information

Petros Pharmaceuticals Inc. (PTPI) registered a -0.27% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.27% in intraday trading to $0.79 this Friday, 08/05/22, hitting a weekly high. The stock’s 5-day price performance is -0.49%, and it has moved by -9.21% in 30 days. Based on these gigs, the overall price performance for the year is -73.76%. The short interest in Petros Pharmaceuticals Inc. (NASDAQ:PTPI) is 21950.0 shares and it means that shorts have 0.08 day(s) to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


While earnings are projected to return 61.10% in 2022.

PTPI Dividends

Petros Pharmaceuticals Inc. is due to release its next quarterly earnings on May 17. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Petros Pharmaceuticals Inc. (NASDAQ:PTPI)’s Major holders

Petros Pharmaceuticals Inc. insiders own 30.06% of total outstanding shares while institutional holders control 4.66%, with the float percentage being 6.67%. Blackrock Inc. is the largest shareholder of the company, while 24 institutions own stock in it. As of Mar 30, 2022, the company held over 0.19 million shares (or 0.93% of all shares), a total value of $0.3 million in shares.

The next largest institutional holding, with 0.13 million shares, is of Marshall Wace LLP’s that is approximately 0.63% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $0.2 million.

Also, the Mutual Funds coming in first place with the largest holdings of Petros Pharmaceuticals Inc. (PTPI) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. Data provided on Mar 30, 2022 indicates that Vanguard Extended Market Index Fund owns about 0.11 million shares. This amounts to just over 0.55 percent of the company’s overall shares, with a $0.18 million market value. The same data shows that the other fund manager holds slightly less at 50225.0, or about 0.24% of the stock, which is worth about $48959.0.

Leave a Comment

Your email address will not be published.

On Key

Related Posts